Oct 8 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
- AstraZeneca blood pressure drug succeeds in late-stage trial
- UK pledges to defend steel industry after EU says it will raise tariffs to 50%
- Ex-KPMG auditor fined for third time in four years for 'serious breaches'
- Jaguar Land Rover to restart UK production after devastating cyber attack
Overview
- AstraZeneca's AZN.L new blood pressure drug succeeded in a late-stage trial, setting the stage for regulatory approval it forecasts could generate up to $5 billion in annual sales.
- Britain vowed to protect its steel industry from "unfair behaviours", as the EU proposed raising steel import tariffs from 25% to 50% and cutting duty-free quotas.
- Britain's accountancy regulator fined former KPMG partner Anthony Sykes 51,187 pounds ($68,549.63) for "serious breaches" of international standards in the firm's 2022 audit of retailer N Brown.
- Jaguar Land Rover, owned by India's Tata Motors TAMO.NS, will resume key UK manufacturing operations on Wednesday after a month-long halt triggered by a cyber attack on August 31.
($1 = 0.7467 pounds)